pembrolizumab,CGX1321
merck,Curegenix
['pembro', 'thank you']
thank you, dr marios giannakis, of , for discussing the phase 1 study of cgx1321 + pembrolizumab in patients with advanced gastrointestinal tumors at the annual meeting. check back here to hear more from the experts: #asco23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.